Clinical Trial Update: A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 rollover study for adult subjects who completed participation in the IMSA101-101 trial, sponsored by ImmuneSensor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• IMSA101

Snippet

Sponsor: ImmuneSensor Therapeutics Inc. | Conditions: Solid Tumor, Adult | Phase 1 | Status: ACTIVE_NOT_RECRUITING